A Study of CS23546 in Subjects With Advanced Tumors

Clinical trial NCT06245122 · RECRUITING

Trial details

NCT number: NCT06245122
Sponsor: Chipscreen Biosciences, Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Tumors

Start date: 2024-03-27
Primary completion: 2027-02-28
Enrollment: 156

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.